• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍心理评估中所用评估方法的增量效度研究综述

Review of Studies on Incremental Validity of Assessment Measures Used in Psychological Assessment of Attention-Deficit Hyperactivity Disorder.

作者信息

Sawaya Helen, Miller Joseph C, Raines Jeremy M

机构信息

University of North Dakota, Grand Forks, USA.

出版信息

Assessment. 2024 Mar;31(2):518-537. doi: 10.1177/10731911231159933. Epub 2023 Mar 13.

DOI:10.1177/10731911231159933
PMID:36914964
Abstract

Few studies have summarized the literature relevant to the incremental validity of tools and procedures for the assessment of attention-deficit hyperactivity disorder (ADHD). The current project reviewed such studies published in the prior 18 years. Results from studies on the incremental validity of measures used in the assessment of ADHD were reviewed. Measures included symptom reports, clinical interviews, behavioral observation, continuous performance and other psychomotor tasks, intelligence tests, and measures of executive function. Twenty-nine published studies and two reviews were identified from 2004 to 2022. Incremental validity was determined using various statistics including , classification metrics, odds ratios, and post-test probabilities. Findings suggest that symptom reports from a collateral source and continuous performance test measures have incremental validity over self-reports and clinical interviews. Measures of intellectual and executive functioning did not show incremental validity in the diagnosis of ADHD. Findings are relevant to the practitioner, as they bear on the optimization of both the cost-effectiveness and the diagnostic accuracy of combined procedures in the assessment of ADHD.

摘要

很少有研究对与注意力缺陷多动障碍(ADHD)评估工具和程序的增量效度相关的文献进行总结。当前项目回顾了过去18年发表的此类研究。对ADHD评估中使用的测量方法的增量效度研究结果进行了回顾。测量方法包括症状报告、临床访谈、行为观察、持续性操作及其他心理运动任务、智力测试和执行功能测量。从2004年到2022年共识别出29项已发表的研究和两项综述。使用包括分类指标、优势比和检验后概率等各种统计方法来确定增量效度。研究结果表明,来自旁证来源的症状报告和持续性操作测试方法相对于自我报告和临床访谈具有增量效度。智力和执行功能测量在ADHD诊断中未显示出增量效度。这些发现对从业者具有参考价值,因为它们关系到ADHD评估中联合程序的成本效益和诊断准确性的优化。

相似文献

1
Review of Studies on Incremental Validity of Assessment Measures Used in Psychological Assessment of Attention-Deficit Hyperactivity Disorder.注意缺陷多动障碍心理评估中所用评估方法的增量效度研究综述
Assessment. 2024 Mar;31(2):518-537. doi: 10.1177/10731911231159933. Epub 2023 Mar 13.
2
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
4
Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.药物治疗注意缺陷多动障碍的成本效益:系统文献回顾。
CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000.
5
Living with symptoms of attention deficit hyperactivity disorder in adulthood: a systematic review of qualitative evidence.成年期注意力缺陷多动障碍症状的生活体验:定性证据的系统综述
JBI Database System Rev Implement Rep. 2017 Apr;15(4):1080-1153. doi: 10.11124/JBISRIR-2017-003357.
6
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
7
Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.非典型抗精神病药物超说明书使用的比较有效性评价综述
J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. doi: 10.18553/jmcp.2012.18.S5-B.1.
8
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
9
Practitioner Review: Clinical utility of the QbTest for the assessment and diagnosis of attention-deficit/hyperactivity disorder - a systematic review and meta-analysis.从业者评论:QbTest 在评估和诊断注意缺陷多动障碍中的临床效用——系统评价和荟萃分析。
J Child Psychol Psychiatry. 2024 Jun;65(6):845-861. doi: 10.1111/jcpp.13901. Epub 2023 Oct 6.
10
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.

引用本文的文献

1
Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder: A Practitioner's Perspective.注意缺陷/多动障碍的诊断与管理:从业者视角
J Clin Med. 2025 Apr 22;14(9):2874. doi: 10.3390/jcm14092874.